LUIS CARCACHE: Open Payments
NPI 1881866796 · HIALEAH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$368 in 12 payments from 8 companies in 2025. Trend: 2023 $23 · 2024 $0 · 2025 $368
Food & beverage: $368
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 1 | $125 |
| Janssen Pharmaceuticals, Inc | 2 | $58 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Vanda Pharmaceuticals Inc. | 1 | $35 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Luye Pharma (USA) Ltd. | 2 | $34 |
| Lundbeck LLC | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
Products named: Qelbree, INVEGA SUSTENNA, COBENFY, FANAPT, Auvelity, ERZOFRI EXTENDED-RELEASE, ABILIFY ASIMTUFII, UZEDY.
Industry payments across FL — which companies pay providers there.
